Cannabis Sativa Stock Forecast, Price & News

+0.01 (+1.41 %)
(As of 04/16/2021 12:00 AM ET)
Today's Range
Now: $0.72
50-Day Range
MA: $0.79
52-Week Range
Now: $0.72
Volume113,315 shs
Average Volume250,842 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. It operates through three divisions: Telemedicine, Contract Manufacturing, and Brand Development and Product Marketing. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology; and operates as a contract manufacturer of products containing hemp-based cannabidiol (CBD). Its products under development include Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; Lip Garden, an emollient balm; and cut cream. The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; owns a patented cannabis sativa plant strain known as Ecuadorian Sativa; and owns intellectual property license for use in medical marijuana edibles and lozenges. In addition, it operates iBudtender, an application for sharing information between cannabis products, patients, and businesses. Cannabis Sativa, Inc. serves CBD and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013. Cannabis Sativa, Inc. was incorporated in 2004 is based in Mesquite, Nevada.
Cannabis Sativa logo

Industry, Sector and Symbol

Industry Personal Services
Current SymbolOTCMKTS:CBDS
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable


Cannabis Quiz: Jim Cramer Gets Put to the Test
April 9, 2021 |  thestreet.com
China Plans Ban of CBD Cosmetics
March 30, 2021 |  msn.com
High anxiety over federal weed loophole
March 27, 2021 |  msn.com
Global $96.17 Billion Medical Marijuana Market to 2026
March 22, 2021 |  finance.yahoo.com
See More Headlines


Overall MarketRank

0.50 out of 5 stars

Services Sector

11th out of 20 stocks

Personal Services Industry

20th out of 34 stocks

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
+0.01 (+1.41 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CBDS News and Ratings via Email

Sign-up to receive the latest news and ratings for CBDS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Cannabis Sativa (OTCMKTS:CBDS) Frequently Asked Questions

What stocks does MarketBeat like better than Cannabis Sativa?

Wall Street analysts have given Cannabis Sativa a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cannabis Sativa wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Cannabis Sativa?

Cannabis Sativa saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 10,100 shares, an increase of 94.2% from the March 15th total of 5,200 shares. Based on an average trading volume of 116,400 shares, the short-interest ratio is currently 0.1 days.
View Cannabis Sativa's Short Interest

How has Cannabis Sativa's stock price been impacted by Coronavirus?

Cannabis Sativa's stock was trading at $0.71 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CBDS shares have increased by 1.4% and is now trading at $0.72.
View which stocks have been most impacted by COVID-19

Who are Cannabis Sativa's key executives?

Cannabis Sativa's management team includes the following people:
  • Mr. David M. Tobias, CEO, Pres, Sec. & Director (Age 70)
  • Ms. Catherine J. Carroll, Treasurer & Director (Age 80)
  • Mr. Brad E. Herr, CFO & Director (Age 67)
  • Ms. Carolyn Merrill, Controller (Age 54)

Who are some of Cannabis Sativa's key competitors?

What other stocks do shareholders of Cannabis Sativa own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cannabis Sativa investors own include (CGC), Cara Therapeutics (CARA), Aurora Cannabis (ACBFF), 22nd Century Group (XXII), Terra Tech (TRTC), United Cannabis (CNAB), Zynerba Pharmaceuticals (ZYNE), Cronos Group (CRON), General Cannabis (CANN) and Cannabis Science (CBIS).

What is Cannabis Sativa's stock symbol?

Cannabis Sativa trades on the OTCMKTS under the ticker symbol "CBDS."

How do I buy shares of Cannabis Sativa?

Shares of CBDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cannabis Sativa's stock price today?

One share of CBDS stock can currently be purchased for approximately $0.72.

How many employees does Cannabis Sativa have?

Cannabis Sativa employs 12 workers across the globe.

What is Cannabis Sativa's official website?

The official website for Cannabis Sativa is www.cannabissativainc.com.

Where are Cannabis Sativa's headquarters?

Cannabis Sativa is headquartered at 1646 W Pioneer Blvd Ste 120, MESQUITE, NV 89027-7515, United States.

How can I contact Cannabis Sativa?

Cannabis Sativa's mailing address is 1646 W Pioneer Blvd Ste 120, MESQUITE, NV 89027-7515, United States. The company can be reached via phone at +1-702-3463906.

This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.